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1. Introduction 
Plasma albumin plays in the organism the impor- 
tant role of a transport protein. Its amino acid se- 
quence has been studied systematically only during 
the past few years. Fragments of bovine [ 1,2] and 
porcine [2] albumin have been investigated in more 
detail. The amino acid sequence of the 24-residue N- 
terminal region of human albumin has been determin- 
ed [3]. The peptides from the neighborhood of the 
only SH-group [4] and the only tryptophan residue 
of human plasma albumin [S] have’been isolated. The 
C-terminal end [6] of its molecule has been character- 
ized by the sequence (Leu, Val, AlaJ_4)Gly - Leu. 
All fragments resulting from specific cleavage of 
human plasma albumin by cyanogen bromide have 
been isolated recently [7-lo] . Six of these peptide 
chains containing 88, 36, 162,95, 110, and 31 amino 
acid residues have C-terminal homoserine. One chain 
composed of 37 amino acids does not contain homose- 
rine [9, lo] . As yet, the amino acid sequence of the 
31-residue chain has been determined [9, 1 l] . The re- 
maining chains have been characterized by sequential 
analysis of five N- and C-terminal amino acid residues 
of each chain. The aim of this study is to report on se- 
quential studies on the C-terminal region of human 
plasma albumin represented by a 37-residue chain not 
containing homoserine. 
2. Material and methods 
The C-terminal chain has been isolated as described 
befbre [lo] from human plasma albumin (Imuna, 
North-Holland Publishing Company - Amsterdam 
Sarisske Michalany, Czechoslovakia). The albumin 
was hydrolyzed by cyanogen bromide in 70% formic 
acid for 22 hr at 5”. For first fractionation a Sephadex 
G-75 column equilibrated with 0.03 M ammonium 
formate at pH 2.86 was used. The material emerging 
as the first peak was oxidized by performic acid, lyo- 
philized, and rechromatographed on the same column. 
The C-terminal chain, contained in the last elution 
peak, was fractionated further on QAE-Sephadex A-25 
in 0.01 M sodium acetate, pH 5.0. A linear elution 
gradient of 0 to 1 .O M NaCl was used. The material 
contained in the main peak was desalted on Sephadex 
G-25 in 0.02 M NH40H. It was designated VII-Asp, 
i.e. by a symbol of its N-terminal amino acid. 
The enzymatic digests of the chains were fraction- 
ated on Whatman No. 3 paper by electrophoresis at 
pH 1.9 and 5.6 [ 12, 131 , and by chromatography in 
systems S 1, n-butanol - pyridine - acetic acid - wa- 
ter (15:10:3:12) or S3, methyl ethyl ketone - tert- 
butanol - water (2:2:1). The methods of amino acid 
analysis and sequential analysis by dansyl-Edman de- 
gradation have been described earlier [8]. 
The chymotryptic digest of chain VII-Asp was pre- 
pared with 2.3 pmole of material. It was dissolved in 
4 ml of 0.05 M NH4 HC03 and digested with the en- 
zyme at a molar ratio of 1:50 for 16 hr at 23”.The 
digest was lyophilized. A sample of 0.12 pmole was 
used for the peptide map (fig. 1). The main portion of 
the digest was prefractionated on a 1.6 X 50 cm col- 
umn of Biogel P2, equilibrated with 0.02 M NH40H. 
A flow rate of 6 ml per hr was maintained and the ab- 
sorbance of the effluent at 260 nm was measured. 
Only two fractions were obtained. They were fraction- 
ated further by chromatography in system S 1 and by 
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Fig. 1. Peptide map of chymotrypsin digest of chain VII-Asp. 
1st direction (horizontally), electrophoresis at pH 5.6, anode 
to the left, 2nd direction (vertically), descending chromato- 
graphy in the system n-butanol-pyridine-acetic acid-water 
(10:15:3:12). S, origin. Reference mixture of amino acids (A 
and B), Lys, Glu, Leu. Peptides Cl through C6. 
electrophoresis at pH 5.6. Peptides Cl to C6 were iso- 
lated. Peptide C2 was digested further with trypsin un- 
der conditions identical to those used for chymotryp- 
tic cleavage. The digest was fractionated electropho- 
retically (pH 5.6) and peptides C2T1, C2T2, and C2T3 
were isolated. 
The tryptic digestion of chain VII-Asp was carried 
out with 10 pmole of the material. It was dissolved in 
4 ml of 0.05M NH4HC03 and hydrolyzed at a molar 
ratio of 1:lOO for 1 hr at 37”. An equal portion of 
trypsin was added afterwards and the digestion was 
continued for 3 hr. The digest was lyophilized and 
then dissolved in 2 ml of 0.02 M Tris-HCl buffer. This 
solution was adjusted to pH 8 by ammonium hydrox- 
ide and fractionated on a Sephadex A-25 column (see 
fig. 2). Peptides Tl, T2, and T3 were obtained. Peptide 
Tl was subsequently digested with chymotrypsin. The 
digest was resolved electrophoretically at pH 5.6. Pep- 
tides TlCl to TlC2 were obtained. 
Peptide T3 (2 /Imole) was dissolved in 1 ml of 0.1 
M NH4HC03, containing 0.001 M CaClz, and digested 
with thermolysin (Calbiochem, B-grade) at a molar ra- 
tio of 1:50 for 6 hr at 37”. The digest was lyophilized 
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Fig. 2. Elution profile of tryptic digest of chain VII-Asp on 
QAE-Sephadex A-25. Column 1.6 x 19 cm, eluted by 0.02 
M Tris-HCI buffer, pH 6.5. Fractions 5.2 ml per 7 min. After 
the emergence of 30 ml of buffer, a linear gradient of 0 to 
0.4 M NaCl in 400 ml of 0.02 M Tris-HCl buffer, pH 6.5, was 
applied. 
and fractionated electrophoretically at pH 1.9. Pep- 
tide T3R3 was isolated from the zone showing the 
same mobility as serine. The main zone, showing the 
mobility of tyrosine, was fractionated in system Sl 
and afforded peptide T3R2. The second zone of a 
Rf-value higher than that of leucine was fractionated 
in system S2 and gave peptides T3Rl and T3R4. 
3. Results and discussion 
The amino acid composition of the C-terminal re- 
gion (VII-Asp) of human plasma albumin is the follow- 
ing: Lyss, Asp,, Thr, Ser, Glus, Gly,, Alas, Cys3, 
ValZ , Leu,, Phe,. The derived amino acid sequence 
of the fragment is shown in fig. 3. The N-terminal 
amino acid sequence of five residues was determined 
by Edman degradation of the intact chain as Asp - 
Asp - Phe - Ala - Ala -. Peptides C 1 through C6, 
isolated from the chymotryptic digest account for 
/,’ :‘: 0.4 I I NaCl (M) 0.2 
Volume 27, number 1 FEBS LETTERS October 1972 
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albumin 
( VII - Asp } 
Human pbsrna 
albumin 
( VII - Asp ) 
CN Br C T r C 
L, , + +,o + ,+ sp-Asp-Phe - A~ - AIo - Phe- k,b[ - Glu - Lys- Cys- Cys - Lys - A[o - Asp -Asp-Lys - Glu - Thr - Cys - Phe- 
- - C I - -  
T1 
T1 El - -  T1 C2- - 
C T T C R C,R R C 
-Ala - GIu - Glu - Gty - Lys - Lys - Leu -Val - A[a - Ala - Ser - Gin - - 
C3 - - C 4 - -  C5~ ~C6~ 
- -T2  T3 
--1"3RI ~ ~T3 R2 ~ ~T3R3- ~T3R4 
C2 
~C2T1~ ~C2T2~ C2T3 
T2- - - -  
Fig. 3. Amino acid sequence of C-terminal region (VII-Asp) of human plasma lbumin. ~ CNBr, ~ C, ~ T, and ~ R denote sites of 
cleavage by cyanogen bromide, chymotrypsin, trypsin, or thermolysin, respectively. ~ Symbolizes the sequence determined by the 
dansyl-Edman degradation method. 
the whole chain. Peptide C 1: Asp - Asp - Phe - Ala 
- Ala - Phe, is identical with the N-terminal region 
of the chain. Peptide C2; Val - Glu - Lys - Cys - 
Cys (Lys2, Asps, Thr, Glu, Ala, Cys, Phe), contains 
all three cysteic acid residues and the only threonine 
residue of the chain. Peptide C2 was digested with 
trypsin and the complete amino acid sequence of the 
resulting peptides was determined as follows. C2TI: 
Val - Glu - Lys, C2T2: Cys - Cys - Lys, C2T3: Ala 
-Asp - Asp - Lys - Glu - Thr - Cys - Phe. Pep- 
tide C3: Ala - Glu - Glu - Gly - Lys - Lys - Leu, 
contains one of the two glycine residues present in the 
chain and one leucine residue. Peptide C4: Val - Ala 
- Ala - Ser -G ln ,  contains the only serine residue of 
the chain. A characteristic feature of peptides C5: Ala 
- Ala - Leu and C6: Gly - Leu, is their content of 
leucine. 
Peptide T 1: Asp - Asp - Phe - Ala (Lys2, Glu, 
Ala, Cys2, Val, Phe), can be assigned to the N-terminus 
of the chain with respect o the sequence of the first 
four amino acids. Chymotryptic digestion of the pep- 
tide afforded peptide T 1C 1: (Asp2, Ala2, Phe2) and 
peptide T1C2: Val - Glu (Lys2, Cys2). The presence 
of glutamic acid in this peptide was determined by 
Edman degradation. The sequence of peptide T2: Ala 
- Asp - Asp - Lys - Glu - Thr (Lys2, Glu2, Gly, 
Ala, Cys, Phe), was elucidated by the same method. 
This peptide represents he middle region of chain 
Vii-Asp and overlaps chymotryptic peptide C2T3. 
Peptide T3: Leu - Val - Ala - Ala - Ser - Gin - 
Ala - Ala (keu~, Gly) contains all three leucine resi- 
dues of chain VII-Asp and completes its C-terminal 
region. The complete amino acid sequence of peptide 
T3 follows from + the sequence of its thermolysin frag- 
ments T3RI:  Leu - Val - Ala, T3R2: Ser -G ln  - 
Ala, T3R3: Ala - Ala, and T3R4: Leu - Gly - Leu. 
The amino acid sequence of peptide T3 is in agree- 
ment with the sequence of the overlapping chymotryp- 
Human ~ Gtu ~ Lys ILys _ Leu_Val. Ata _ Ala _ Ser .~ALa  ~ G L y  _ keu. 
Bovine .~ F'he- Ala t Vat-~ Glu- GLy t P r° t  Lys -Leu -VQ[ I Vat -  Ser- Thr ~ Thr t ALa- Leu -t Ata. 
Fig. 4. Comparison of amino acid sequence of C-terminal region of human and bovine plasma lbumin. 
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tic peptides C4, CS, and C6. 
No microheterogeneity in the primary structure of 
human plasma albumin was observed during the se- 
quential studies on chain VII-Asp. Fig. 4 shows the de- 
gree of homology between a part of the 37-residue C- 
terminal region of human plasma albumin reported 
here and the corresponding part of bovine plasma al- 
bumin described by other authors [2] . 
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